135
Participants
Start Date
April 10, 2024
Primary Completion Date
February 5, 2025
Study Completion Date
March 31, 2026
BB-1701
BB-1701 will be administered as an intravenous infusion, every 3 weeks (21-day cycle).
Memorial Sloan-Kettering Cancer Center, New York
AdventHealth Cancer Institute - Orlando, Orlando
Cleveland Clinic - Fairview Hospital - Cancer Center (Moll Cancer Center), Cleveland
Cleveland Clinic - Hillcrest Hospital - Hillcrest Cancer Center, Cleveland
Community Cancer Center South, Indianapolis
Fort Wayne Medical Oncology & Hematology, Fort Wayne
Mission Blood and Cancer, Des Moines
Avera Cancer Institute, Sioux Falls
NHO Revive Research Institute LLC, Lincoln
New Mexico Oncology Hematology Consultants, Albuquerque
UCLA Center for East-West Medicine, Los Angeles
Cancer and Blood Specialty Clinic, Los Alamitos
Oregon Oncology Specialists, Salem
UCSF, San Francisco
Yale New Haven Hospital, New Haven
Moffitt Cancer Center, Tampa
University of Michigan Hospital, Ann Arbor
Washington University in St. Louis School of Medicine, St Louis
Nebraska Cancer Specialist, Omaha
Astera Cancer Care, East Brunswick
Summit Medical Group, Florham Park
Rutgers Cancer Institute of New Jersey, New Brunswick
Cleveland Clinic, Cleveland
UPMC CancerCenter at Magee - Womens Hospital, Pittsburgh
St. Francis Cancer Center, Greenville
The West Clinic, PLLC dba West Cancer Cente, Germantown
Northwest Medical Specialties, Puyallup
CHU Besançon - Hôpital Jean Minjoz, Besançon
Institut Régional du Cancer de Montpellier, Montpellier
Centre Armoricain de Radiotherapie Imagerie & Oncologie (CARIO), Plérin
Institut de Cancerologie de Ouest (ICO) - Saint-Herblain, Saint-Herblain
Nagoya University Hospital, Nagoya
Hiroshima City Hiroshima Citizens Hospital, Hiroshima
Hokkaido University Hospital, Sapporo
Hyogo Medical University Hospital, Nishinomiya-shi
Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima
Kanagawa Cancer Center, Yokohama
National Cancer Center Hospital (NCCH), Chūōku
Kyoto University Hospital, Sakyo-ku
Tohoku University Hospital, Sendai
Okayama University Hospital, Okayama
Saitama Medical University International Medical Center, Hidaka-shi
Saitama Cancer Center, Kitaadachi-gun
St. Luke's International Hospital, Chuou-ku
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto Ku
Showa University, Shinagawa Ku
Hospital Universitario Vall d'Hebron, Barcelona
HM Universitario Sanchinarro, Madrid
Hospital Beata María Ana, Madrid
Bliss Biopharmaceutical (Hangzhou) Co., Ltd
INDUSTRY
Eisai Inc.
INDUSTRY